Analysts Offer Insights on Financial Companies: First American Financial (FAF) and Renaissancere Holdings (RNR)
Evercore ISI Sticks to Its Sell Rating for Renaissancere Holdings (RNR)
Buy Rating Affirmed for Tenet Healthcare on Strong Financials and Growth Prospects
JPMorgan Adjusts Price Target on RenaissanceRe to $267 From $265, Maintains Neutral Rating
RenaissanceRe Price Target Raised to $267.00/Share From $265.00 by JP Morgan
RenaissanceRe Holdings Analyst Ratings
Tenet Healthcare Price Target Raised to $168.00/Share From $112.00 by Cantor Fitzgerald
Tenet Healthcare Analyst Ratings
Morgan Stanley Maintains RenaissanceRe Holdings(RNR.US) With Hold Rating, Maintains Target Price $240
Loop Capital Maintains Carlisle Companies(CSL.US) With Buy Rating, Maintains Target Price $475
Oppenheimer Maintains Carlisle Companies(CSL.US) With Buy Rating, Raises Target Price to $475
Carlisle Companies (CSL) Receives a Rating Update From a Top Analyst
Analysts Offer Insights on Industrial Goods Companies: Nordson (NDSN) and Carlisle Companies (CSL)
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $170
Truist Raises Price Target on Tenet Healthcare to $170 From $155, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Tenet Healthcare (THC)
Wells Fargo Maintains RenaissanceRe Holdings(RNR.US) With Buy Rating, Maintains Target Price $288
Citi Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $171
Tenet Healthcare (THC) Receives a Buy From Citi
Buy Rating Affirmed on Renaissancere Holdings Amid Strong Q2 Earnings and Strategic Capital Management